The Rare Disease Company Coalition
Active 2021–2026. The register lists this client once for every firm that files on its behalf; all 4 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2026 | FEROX STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2026 | RARE DISEASE COMPANY COALITION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$80,000 | |
| 2026 | FEROX STRATEGIES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2026 | RARE DISEASE COMPANY COALITION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$70,000 | |
| 2026 | RARE DISEASE COMPANY COALITION |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$110,000 | |
| 2026 | FEROX STRATEGIES |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$50,000 | |
| 2025 | FEROX STRATEGIES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2025 | RARE DISEASE COMPANY COALITION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$70,000 | |
| 2025 | FEROX STRATEGIES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2025 | RARE DISEASE COMPANY COALITION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$90,000 |
| Firm | Filings | Amount |
|---|---|---|
| THE KPM GROUP DC LLC | 17 | $1,100,000 |
| RARE DISEASE COMPANY COALITION IN-HOUSE | 8 | $550,000 |
| FEROX STRATEGIES | 7 | $300,000 |
| LMH STRATEGIC SOLUTIONS | 2 | $40,000 |
| Issue | Activities |
|---|---|
| Pharmacy | 24 |
| Health Issues | 15 |
| Trade (domestic/foreign) | 9 |
| Taxation/Internal Revenue Code | 8 |
| Science/Technology | 4 |
| Medicare/Medicaid | 3 |
| Budget/Appropriations | 2 |